Time period: 2021-2023
|
Organisation |
National |
| Number of oesophago-gastric (OG) cancer patients in audit |
80 |
19,512 |
| Diagnosis |
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations |
23% |
21.0% |
– % diagnosed with stage 4 disease
(denominator: all people diagnosed) |
44% |
37.0% |
– % with unknown stage
(denominator: all people diagnosed) |
6% |
17.0% |
| Waiting times |
– % diagnosed within 28 days of referral
(denominator: people diagnosed after urgent GP referral) |
87% |
73.0% |
– % treated within 62 days of referral
(denominator: people receiving disease-targeted treatment after urgent GP referral) |
37% |
26.0% |
| Supportive care |
– % seen by a clinical nurse specialist (CNS) at diagnosis
(denominator: people with complete CNS data) |
100% |
93.0% |
– % seen by a clinical nurse specialist (CNS) at diagnosis
(denominator: all people diagnosed) |
80% |
60.0% |
| – % with complete CNS data |
80% |
65.0% |
N/A: results not presented due to a denominator of <10; for the CNS indicators, results are not presented if the denominator is <10 or if data completeness of the CNS variable is poor (<50%)